Novanta (NOVT) Q4 2024 earnings summary

Executive summary

• Achieved solid financial results in 2024, returning to organic growth in Q4, beating profit expectations, and delivering record quarterly and annual cash flow.

• Q4 2024 GAAP revenue rose 13% year-over-year to $238 million, with organic revenue growth of 3.4% and a $2 million FX headwind; full year GAAP revenue increased 8% to $949 million, with organic revenue down 1.6%.

• Adjusted EBITDA for 2024 grew 7% to $210 million; operating cash flow up 32% to $159 million.

• Launched 50 new products in 2024, with strong initial orders and a robust innovation pipeline for 2025.

• Reorganized leadership with two new Co-COOs to scale both organically and through acquisitions.

Financial highlights

• Q4 2024 revenue: $238M (3% organic growth YoY, 13% reported growth); full year revenue: $949M (+8% reported, 2% organic decline).

• Q4 adjusted gross margin: 47%; core businesses expanded margins by 125 bps; Q4 adjusted EBITDA: $52M (+15% YoY); full year adjusted EBITDA: $210M (+7% YoY).

• Q4 operating cash flow: $62M (+58% YoY, record); full year: $159M (+32% YoY, record).

• Q4 non-GAAP EPS: $0.76 (+21% YoY); full year: $3.08.

• Ended 2024 with $416.6M total debt, $114M cash, and $305.2M net debt.

Outlook and guidance

• 2025 revenue guidance: ~$1B (+5% YoY), driven by $50M incremental new product sales.

• Adjusted gross margin expected to expand by 100 bps to 47–47.5%.

• Adjusted EBITDA guidance: $225–$235M (23% margin); adjusted EPS: $3.35–$3.55 (+9–15% YoY).

• Cash flow expected to grow, with >100% cash conversion of non-GAAP net income.

• Q1 2025 revenue guidance: $232–$236M (flat to +2% YoY); Q1 adjusted EPS: $0.63–$0.71.